| Thursday, April 4, 2019 |
|
|
CHEO Research Institute 2018-19 CHAMO Innovation Fund competition
|
| The CHEO Research Institute is happy to announce the results of the 2018-19 CHAMO Innovation Fund competition. Funds from the competition are to support the development of new and innovative approaches to health care delivery and to provide leadership in the dissemination of new knowledge across the healthcare system. These projects will no doubt impact healthcare delivery and offer opportunities to translate new knowledge into medical practice locally and nationally.
Read More
| |
| Tuesday, April 2, 2019 |
|
|
Defining obesity in children should be based on health issues, not just BMI
|
| Ottawa, ON (April 2, 2019) – Physicians are told to gauge the severity of a child’s obesity using the body mass index (BMI) that measures weight against height. But that doesn’t work well to identify health issues, especially those of mental and cardio-metabolic health, in children with obesity seeking care, according to a new paper published in The Lancet Child & Adolescent Health.
Read More
| |
| Thursday, March 7, 2019 |
|
|
Dr. Jason Berman announced as new CEO and Scientific Director of CHEO RI and VP Research of CHEO
|
The following is a letter to partners from Alex Munter, CHEO’s President and CEO, and Caroline Somers, the Board Chair of the CHEO Research Institute
OTTAWA, March 7, 2019 - On behalf of the Boards of Directors of CHEO and the CHEO Research Institute (RI), we are pleased to share that Dr. Jason Berman will be the new CEO and Scientific Director of the CHEO RI and the VP Research of CHEO.
Dr. Berman joins us from Halifax’s IWK Health Centre and Dalhousie University, where he is the Interim Vice President Research, Innovation and Knowledge Translation, Associate Chair Research, Department of Pediatrics, and Full Professor in the Departments of Pediatrics, Pathology and Microbiology & Immunology at the Faculty of Medicine.
Read More
| |